Recent Price Movement and Market Context
Epigral's share price increase on 28-Nov outpaced its sector by 2.22%, signalling a short-term positive momentum. The stock has outperformed the Sensex over the past week, gaining 4.02% compared to the benchmark's 0.56%. However, this contrasts sharply with its one-month and year-to-date returns, which stand at -10.55% and -20.16% respectively, while the Sensex has posted gains of 1.27% and 9.68% over the same periods. Over the last year, the stock has declined by 26.82%, underperforming the Sensex's 8.43% rise. This divergence highlights the stock's recent resilience amid broader underperformance.
Intraday, the stock reached a high of ₹1,517, trading above its five-day moving average but remaining below longer-term averages suc...
Read More













